• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TANDEM DIABETES CARE T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY; AUTOMATED INSULIN DOSING, THRESHOLD SUSPEND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TANDEM DIABETES CARE T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY; AUTOMATED INSULIN DOSING, THRESHOLD SUSPEND Back to Search Results
Model Number 1002717
Device Problem Obstruction of Flow (2423)
Patient Problems Chest Pain (1776); Vomiting (2144)
Event Date 10/23/2021
Event Type  Injury  
Manufacturer Narrative
No product was returned for evaluation.Should new relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that the customer experienced an elevated blood glucose (bg) level of 324-325 mg/dl, vomiting, chest pain, and a 6.2 mmol/l ketone level resulting in a hospitalization.At the time of the event, the customer had received multiple occlusions.No issues were observed with the cartridge, infusion set cannula, infusion set tubing, or insulin in use at the time of the event; the pump wsas confirmed to be working as intended at the time of the event.A correction bolus was delivered to address the adverse event prior to the hospitalization.While hospitalized, the customer was treated with intravenous saline and insulin.The customer was discharged from the hospital; no release date was confirmed as customer declined to provide this information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY
Type of Device
AUTOMATED INSULIN DOSING, THRESHOLD SUSPEND
Manufacturer (Section D)
TANDEM DIABETES CARE
11075 roselle street
san diego CA 92121
Manufacturer Contact
mick trier
san diego, CA 92121
8584011451
MDR Report Key12797722
MDR Text Key280692565
Report Number3013756811-2021-119618
Device Sequence Number1
Product Code OZO
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K201214
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 11/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Model Number1002717
Device Catalogue Number1002684-D
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Manufacturer Received10/23/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/01/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
INSULIN: NOVOLOG/NOVORAPID
Patient Outcome(s) Hospitalization; Required Intervention;
Patient EthnicityNon Hispanic
-
-